-
1
Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients
Published 2022-12-01Get full text
Article -
2
Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients
Published 2022-08-01Get full text
Article -
3
-
4
Circulating microRNA Biomarkers of Thiazide Response in Hypertension
Published 2024-02-01Get full text
Article -
5
-
6
Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network
Published 2021-07-01Get full text
Article -
7
-
8
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic
Published 2020-07-01Get full text
Article -
9
-
10
-
11
-
12
-
13
-
14
A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps
Published 2023-06-01“…Eda Eken,1,2 David S Estores,3 Emily J Cicali,1,2 Kristin K Wiisanen,1,2 Julie A Johnson1,2 1Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA; 2Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, FL, USA; 3Division of Gastroenterology, Hepatology, and Nutrition, College of Medicine, University of Florida, Gainesville, FL, USACorrespondence: Julie A Johnson, University of Florida, Department of Pharmacotherapy and Translational Research, Box 100486, Gainesville, FL, 32610-0486, USA, Tel +1-352-273-6310, Email Julie.johnson@ufl.eduAbstract: Proton pump inhibitors (PPIs) are commonly used medications to treat acid-related conditions, including gastro-esophageal reflux disease (GERD). …”
Get full text
Article